Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
about
Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.Exercise therapy for claudication: latest advances.The role of exercise training in peripheral arterial disease.Community walking programs for treatment of peripheral artery disease.Extracorporeal shock wave therapy for ischemic cardiovascular disorders.A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis.Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease.Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo.Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry.
P2860
Q30430614-48E42A43-1ABB-4DD8-9866-B49E86D953E4Q36769103-85062027-07E7-44DA-AB6D-0537803AB83BQ37019605-284EEF48-0F33-45B4-8F8E-A4C29593A174Q37524438-AA7FFCA5-A467-423F-8629-7FDC33A83695Q37918523-D68E2F60-1EB3-4D34-9E1D-D43C05989F60Q38029478-0AEE9F5C-B4DF-4DD8-BD73-EB73015C7421Q38122999-16F0F5DE-1331-4FDA-9BA9-6D0C2F2C7159Q41904181-CBB31CF8-40E4-4465-80CE-618E53BCE27FQ42135252-2F759012-42CB-44B8-A0CA-7D898D97B277Q42192191-EC792C1F-AA98-41E8-8ADD-DE94B8B366E1Q50460187-0E6DA3DD-F9A8-4F07-A7A5-D3F606CF61E1Q50595404-BA27B2AD-86DA-4629-8D04-870F08A54585Q53586728-F61AF613-8037-4A92-99A6-2BF14A175DF8
P2860
Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Established and evolving medic ...... h peripheral arterial disease.
@ast
Established and evolving medic ...... h peripheral arterial disease.
@en
type
label
Established and evolving medic ...... h peripheral arterial disease.
@ast
Established and evolving medic ...... h peripheral arterial disease.
@en
prefLabel
Established and evolving medic ...... h peripheral arterial disease.
@ast
Established and evolving medic ...... h peripheral arterial disease.
@en
P2860
P356
P1476
Established and evolving medic ...... h peripheral arterial disease.
@en
P2093
Judith G Regensteiner
Kerry J Stewart
P2860
P304
P356
10.1038/NCPCARDIO0660
P577
2006-11-01T00:00:00Z